Literature DB >> 24862414

Uncontrolled asthma and recurring pulmonary opacities: just asthma?

Jesper Rømhild Davidsen1, Poul Henning Madsen2, Christian B Laursen3.   

Abstract

In asthma, when comorbidities and common causes of poor control have been considered and treated, the clinician may speculate, 'Is it all asthma?'. In patients with uncontrolled atopic asthma with recurring episodes of symptoms mimicking pneumonia, the suspicion of allergic bronchopulmonary aspergillosis (ABPA) should remain high. ABPA is caused by a complex immunological hypersensitivity reaction to colonisation with Aspergillus fumigatus in the bronchial tree, and is characterised by the presence of atopic asthma, blood eosinophilia, migrating pulmonary opacities and potential bronchiectasis. This case report describes a delay in diagnosing ABPA which was imitating pneumonia. The clinician should pay increased attention to ABPA and test for this in patients with uncontrolled asthma with an ongoing requirement for oral corticosteroids and/or antibiotics and with pulmonary opacities on chest imaging. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24862414      PMCID: PMC4039853          DOI: 10.1136/bcr-2013-202428

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Asthma control in Europe: a real-world evaluation based on an international population-based study.

Authors:  Lucia Cazzoletti; Alessandro Marcon; Christer Janson; Angelo Corsico; Deborah Jarvis; Isabelle Pin; Simone Accordini; Enrique Almar; Massimiliano Bugiani; Adriana Carolei; Isa Cerveri; Enric Duran-Tauleria; David Gislason; Amund Gulsvik; Rain Jõgi; Alessandra Marinoni; Jesús Martínez-Moratalla; Paul Vermeire; Roberto de Marco
Journal:  J Allergy Clin Immunol       Date:  2007-11-05       Impact factor: 10.793

Review 2.  Pulmonary aspergillosis: a clinical review.

Authors:  M Kousha; R Tadi; A O Soubani
Journal:  Eur Respir Rev       Date:  2011-09-01

Review 3.  Diagnosis and management of allergic bronchopulmonary aspergillosis.

Authors:  P A Greenberger; R Patterson
Journal:  Ann Allergy       Date:  1986-06

4.  Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis.

Authors:  M Rosenberg; R Patterson; R Mintzer; B J Cooper; M Roberts; K E Harris
Journal:  Ann Intern Med       Date:  1977-04       Impact factor: 25.391

5.  A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis.

Authors:  D A Stevens; H J Schwartz; J Y Lee; B L Moskovitz; D C Jerome; A Catanzaro; D M Bamberger; A J Weinmann; C U Tuazon; M A Judson; T A Platts-Mills; A C DeGraff
Journal:  N Engl J Med       Date:  2000-03-16       Impact factor: 91.245

6.  Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial.

Authors:  Peter Alexander Blanch Wark; Michael John Hensley; Nicholas Saltos; Michael James Boyle; Ruth Christine Toneguzzi; Grad Dip Clin Epid; Jodie Louise Simpson; Patrick McElduff; Peter Gerard Gibson
Journal:  J Allergy Clin Immunol       Date:  2003-05       Impact factor: 10.793

Review 7.  Allergic bronchopulmonary aspergillosis.

Authors:  Ritesh Agarwal
Journal:  Chest       Date:  2009-03       Impact factor: 9.410

Review 8.  Clinical phenotypes of asthma.

Authors:  Elisabeth H Bel
Journal:  Curr Opin Pulm Med       Date:  2004-01       Impact factor: 3.155

  8 in total
  1 in total

1.  Uncommon condition mimicking non-resolving pneumonia and malignancy on radiography that improves dramatically with a course of steroids.

Authors:  Alexander Sanders; Max Matonhodze
Journal:  BMJ Case Rep       Date:  2016-03-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.